ZyVersa Therapeutics, Inc.
ZVSA
$0.1221
-$0.0079-6.08%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.21M | -2.26M | -1.42M | -2.40M | -2.76M |
| Total Depreciation and Amortization | -- | -- | -7.80K | 1.70K | 2.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 188.00K | 153.90K | 283.10K | 160.70K | 170.40K |
| Change in Net Operating Assets | 501.60K | 331.00K | -78.20K | 1.59M | 676.70K |
| Cash from Operations | -1.52M | -1.77M | -1.22M | -644.40K | -1.91M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 2.00M | 3.04M | 828.00K | 0.00 |
| Repurchase of Common Stock | -2.00M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.98M | -147.10K | -407.90K | -180.10K | -- |
| Cash from Financing | -17.70K | 1.85M | 2.63M | 647.80K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.54M | 80.60K | 1.41M | 3.40K | -1.91M |